With diagnostics for Alzheimer's already approved and therapeutics in late-stage clinical trials, the next hurdle is to translate these advances into clinical practice. The Davos Alzheimer's Collaborative is working on it.
Researchers have examined the advantages of employing soft robotic systems and humanoid musculoskeletal robots as bioreactor platforms to create clinically effective tendon constructions.
starting to be offered? i such a speed that the real hope is starting to be offered? starting to be offered? i think so, i think a lot starting to be offered? i think so, i think a lot of starting to be offered? i think so, i think a lot of the starting to be offered? i think so, i think a lot of the technologies i i think a lot of the technologies that have come in are becoming more accessible to patients in general and through the nhs. i think we are taking those advances into clinic. i think there is, again it used to be that science is done for science purposes and then medicine was different but that translational clap is being breached, translational gap,. i think again that this is the sort of programme that this is the sort of programme that will enable that and even advances that have not yet come to pass, as they are discovered, will be able to adopt the framework that we have, you know, envisaged and actioned here in cambridge, they will be able to jump on that ban